Garda Capital Partners’s Medtronic MDT Stock Holding History

Garda Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-75,500	Closed	-$6.58M	–	283
2025 Q2	$6.58M	Buy	75,500 +9,700	+15%	+$823K	0.16%	158
2025 Q1	$5.91M	Buy	+65,800	New	+$5.89M	0.15%	200
2024 Q4	–	Sell	-23,000	Closed	-$2.07M	–	390
2024 Q3	$2.07M	Buy	23,000 +4,000	+21%	+$336K	0.06%	311
2024 Q2	$1.5M	Buy	+19,000	New	+$1.56M	0.05%	286
2023 Q4	–	Sell	-28,500	Closed	-$2.23M	–	615
2023 Q3	$2.23M	Sell	28,500 -29,000	-50%	-$2.43M	0.1%	199
2023 Q2	$5.07M	Buy	+57,500	New	+$4.95M	0.28%	84

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Garda Capital Partners's MDT Position: Q3 2025 in Review

Garda Capital Partners sold out of Medtronic (MDT) in Q3 2025, closing a stake of 3,392 shares — an estimated $296K sold.

Garda Capital Partners first reported a position in MDT in Q3 2023 and held it in 2 quarters. The position peaked at $1.71M in Q3 2023. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

Garda Capital Partners reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
Garda Capital Partners sold 3,392 Medtronic shares in Q3 2025, an estimated $296K.
Garda Capital Partners first reported a position in Medtronic in Q3 2023 and held it in 2 quarters.
Garda Capital Partners's Medtronic position peaked at $1.71M in Q3 2023.
2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Garda Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.